Yarrow Bioscience, Inc. Common Stock
YARW
35 hedge funds and large institutions have $116M invested in Yarrow Bioscience, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 14 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
8% less funds holding
Funds holding: 38 → 35 (-3)
21% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 14
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
80% less capital invested
Capital invested by funds: $579M → $116M (-$463M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$3.38M |
| 2 |
Millennium Management
New York
|
+$2.29M |
| 3 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$816K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$661K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$544K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$16M |
| 2 |
VMI
VHCP Management II
New York
|
-$12.8M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$12.7M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$7.52M |
| 5 |
PA
Perceptive Advisors
New York
|
-$3.85M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
51
Franklin Resources
San Mateo,
California
| – | -$7.52M | -56 | Closed |
|
|
NC
52
Nexthera Capital
New York
| – | -$2.79M | -21 | Closed |
|
|
GPP
53
Great Point Partners
Greenwich,
Connecticut
| – | -$1.95M | -14 | Closed |
|
|
MWNA
54
Marshall Wace North America
New York
| – | -$1.18M | -9 | Closed |
|
|
LCM
55
Landscape Capital Management
Englewood,
New Jersey
| – | -$1.12M | -8 | Closed |
|
|
EAM
56
Eventide Asset Management
Boston,
Massachusetts
| – | -$940K | -7 | Closed |
|
|
LCM
57
Laurion Capital Management
New York
| – | -$481K | -4 | Closed |
|
|
TCIM
58
TIAA CREF Investment Management
New York
| – | -$448K | -3 | Closed |
|
|
GPCM
59
Granite Point Capital Management
Boston,
Massachusetts
| – | -$304K | -2 | Closed |
|
|
SO
60
STRS Ohio
Columbus,
Ohio
| – | -$67K | -1 | Closed |
|
|
CCA
61
Catalyst Capital Advisors
Huntington,
New York
| – | -$9K | – | – |
|
YARW Hedge Fund Activity: Q2 2018 in Review
35 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Yarrow Bioscience, Inc. Common Stock (YARW) for Q2 2018, worth a combined $116M — down 80% from $579M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of YARW and 11 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 7 added.
The largest buyer was DAFNA Capital Management, opening a new position worth an estimated $3.38M. The largest seller was Deerfield Management, exiting entirely with an estimated $16M sold.
- 35 institutional investors held Yarrow Bioscience, Inc. Common Stock (YARW) as of Q2 2018, down from 38 in Q1 2018.
- Funds reported $116M of Yarrow Bioscience, Inc. Common Stock stock for Q2 2018, down 80% quarter-over-quarter.
- 11 funds opened new Yarrow Bioscience, Inc. Common Stock positions in Q2 2018 and 14 closed out, a net change of -3 holders.
- The largest Yarrow Bioscience, Inc. Common Stock buyer in Q2 2018 was DAFNA Capital Management, an estimated $3.38M added.
- The largest Yarrow Bioscience, Inc. Common Stock seller in Q2 2018 was Deerfield Management, an estimated $16M sold.
Based on aggregated 13F filings for Q2 2018.